These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20728364)

  • 21. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
    Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
    J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
    Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
    Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs.
    Monks NR; Pardee AB
    J Cell Biochem; 2006 May; 98(1):221-33. PubMed ID: 16408291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines.
    Mukhopadhyay A; Bueso-Ramos C; Chatterjee D; Pantazis P; Aggarwal BB
    Oncogene; 2001 Nov; 20(52):7597-609. PubMed ID: 11753638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis.
    Poma P; Notarbartolo M; Labbozzetta M; Maurici A; Carina V; Alaimo A; Rizzi M; Simoni D; D'Alessandro N
    Int J Mol Med; 2007 Sep; 20(3):329-35. PubMed ID: 17671737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New cytotoxic saturated and unsaturated cyclohexanones from Anthemis maritima.
    Collu F; Bonsignore L; Casu M; Floris C; Gertsch J; Cottiglia F
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1559-62. PubMed ID: 18262418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway.
    Li Z; Li J; Mo B; Hu C; Liu H; Qi H; Wang X; Xu J
    Toxicol In Vitro; 2008 Oct; 22(7):1749-53. PubMed ID: 18761399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.
    Labbozzetta M; Notarbartolo M; Poma P; Maurici A; Inguglia L; Marchetti P; Rizzi M; Baruchello R; Simoni D; D'Alessandro N
    Ann N Y Acad Sci; 2009 Feb; 1155():278-83. PubMed ID: 19250217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of NFkappaB is inhibited by curcumin and related enones.
    Weber WM; Hunsaker LA; Roybal CN; Bobrovnikova-Marjon EV; Abcouwer SF; Royer RE; Deck LM; Vander Jagt DL
    Bioorg Med Chem; 2006 Apr; 14(7):2450-61. PubMed ID: 16338138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells.
    Sharma C; Kaur J; Shishodia S; Aggarwal BB; Ralhan R
    Toxicology; 2006 Nov; 228(1):1-15. PubMed ID: 16996673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
    Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
    Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
    Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA
    Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
    Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
    Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel curcumin analogs targeting TNF-induced NF-kappaB activation and proliferation in human leukemic KBM-5 cells.
    Zambre AP; Kulkarni VM; Padhye S; Sandur SK; Aggarwal BB
    Bioorg Med Chem; 2006 Nov; 14(21):7196-204. PubMed ID: 16843665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
    Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
    Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of structurally simplified analogues of aplidinone A, a pro-apoptotic marine thiazinoquinone.
    Aiello A; Fattorusso E; Luciano P; Menna M; Calzado MA; Muñoz E; Bonadies F; Guiso M; Sanasi MF; Cocco G; Nicoletti R
    Bioorg Med Chem; 2010 Jan; 18(2):719-27. PubMed ID: 20031419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
    Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
    Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells.
    Dandawate P; Khan E; Padhye S; Gaba H; Sinha S; Deshpande J; Venkateswara Swamy K; Khetmalas M; Ahmad A; Sarkar FH
    Bioorg Med Chem Lett; 2012 May; 22(9):3104-8. PubMed ID: 22483392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel curcumin-like dienone induces apoptosis in triple-negative breast cancer cells.
    Robles-Escajeda E; Das U; Ortega NM; Parra K; Francia G; Dimmock JR; Varela-Ramirez A; Aguilera RJ
    Cell Oncol (Dordr); 2016 Jun; 39(3):265-77. PubMed ID: 26920032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-proliferative, Cytotoxic and NF-ĸB Inhibitory Properties of Spiro(Lactone-Cyclohexanone) Compounds in Human Leukemia.
    Bouhenna MM; Orlikova B; Talhi O; Schram B; Pinto DCGA; Taibi N; Bachari K; Diederich M; Silva AMS; Mameri N
    Anticancer Res; 2017 Sep; 37(9):5225-5233. PubMed ID: 28870958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.